Robot-assisted Training with the H2 Exoskeleton for Stroke
(H2-NeuroExo Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how the H2 Lower Limb Exoskeleton, a smart robotic exoskeleton, can aid in regaining walking abilities after a stroke. It will compare traditional physical therapy with robot-assisted exercises and examine the role of brain waves in using the exoskeleton. Participants must have experienced a stroke at least three months prior and be able to stand with support for five minutes. The study seeks to design devices that individuals can control with their thoughts to assist in walking again. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could revolutionize stroke rehabilitation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the H2 Exoskeleton is safe for stroke rehabilitation?
Research has shown that the H2 Lower Limb Exoskeleton is generally safe for aiding stroke recovery. In one study with three stroke patients, participants tolerated the training well, and no negative effects were reported. This suggests the exoskeleton can be used safely. The smart robotic device assists with walking and leg exercises, aiming to help those who have lost some or all of their ability to walk. Although these findings are preliminary, they offer reassurance about the device's safety in human trials.12345
Why are researchers excited about this trial?
Researchers are excited about the H2 Lower Limb Exoskeleton for stroke rehabilitation because it offers a novel approach by using robot-assisted technology. Unlike traditional physical therapy, which relies on manual exercises, this exoskeleton provides consistent and precise movements, potentially enhancing motor recovery more efficiently. Additionally, the exoskeleton can offer personalized support, adapting to each patient's needs, which may lead to improved outcomes in regaining mobility.
What evidence suggests that the H2 Exoskeleton is effective for stroke rehabilitation?
Research has shown that robotic exoskeletons, such as the H2, can help stroke patients improve their walking through repeated practice. In this trial, participants in the Robot-assisted Rehabilitation arm will train with the H2 exoskeleton, which supports the hips, knees, and ankles to aid movement. Studies indicate that these exoskeletons can help stroke patients walk faster. The H2 exoskeleton assists with walking, making it easier for users. Early findings suggest that this technology can effectively aid recovery after a stroke.12678
Who Is on the Research Team?
Jose L Pons, PhD
Principal Investigator
Spanish Research Council
Gerard E Francisco, MD
Principal Investigator
TIRR Memorial Hermann Hospital
Jose L Contreras-Vidal, PhD
Principal Investigator
University of Houston
Are You a Good Fit for This Trial?
This trial is for adults aged 18-75 who've had a stroke at least 3 months ago, can stand and walk with assistance, have mild to moderate disability, normal cognitive ability (score >24 on Mini Mental State Exam), and controlled muscle stiffness. It's not for those with severe cognitive/visual deficits, other medical issues preventing rehab, severe sensory loss or joint contractures affecting walking.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either supervised motor practice or robot-assisted training with the H2 lower limb powered exoskeleton for 4 weeks, with 3 sessions per week, each lasting about 1.5 hours
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2 weeks and 2 months post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- H2 Lower Limb Exoskeleton
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Houston
Lead Sponsor
TIRR Memorial Hermann
Collaborator
The University of Texas Health Science Center, Houston
Collaborator